In addition, similar to Parkinson’s disease, several therapeutic studies yielded positive outcomes of non-radioactive Cu-ATSM in SOD1-mutant mouse models of ALS, including improved locomotive function and overall survival [141,142]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.